NAGENDRAN SUKUMAR

PrivateCIK: 1665124
Location

BANNOCKBURN, IL

NAGENDRAN SUKUMAR sold 16.6% of their position (200K shares) of TAYSHA GENE THERAPIES, INC. on the open market

Open‑market sale worth $942.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderNAGENDRAN SUKUMARCIK 1665124
Director
Since Sep 2020
+501K
Net shares
Net buyer
$942.0K
Total sold
1
Open market trades
0B · 1S
7
Total transactions
901K acquired · 400K disposed
Non-Derivative Transactions4

Common Stock

Direct
M · Option Exercise

Shares

+111.32K

Price / share

$0.70

Trade value

$77.80K

% of position

11.1%
1/12/2026
1.01M1.12M

Common Stock

Direct
M · Option Exercise

Shares

+88.68K

Price / share

$1.71

Trade value

$151.64K

% of position

7.9%
1/12/2026
1.12M1.21M

Common Stock

Direct
S · Sale

Shares

200K

Price / share

$4.71

Trade value

$942K

% of position

16.6%
1/12/2026
1.21M1.01M

Common Stock

Direct
A · Award

Shares

+427K

Price / share

Trade value

% of position

42.4%
1/12/2026
1.01M1.43M
Total

Net shares

+427K

Net value

-$712.56K

Derivative Transactions3

Employee Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

111.32K shares

Shares

111.32K

Strike price

0.6989

Held after

111.36K

Exercisable

1/12/2026

Employee Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

88.68K shares

Shares

88.68K

Strike price

1.71

Held after

474.94K

Exercisable

1/12/2026

Employee Stock Option (right to buy)

Direct
A · Award
Converts to

Common Stock

274K shares

Shares

+274K

Strike price

4.86

Held after

274K

Exercisable

1/12/2026
NAGENDRAN SUKUMAR — Insider Transaction (Form 4) Filed Jan 14, 2026 | Finecho